Nontuberculous mycobacteria (NTM) causing human infectious disease have become increasingly common. Rapid and accurate identification to the species level is, therefore, critical. The Speed-Oligo Mycobacteria assay is an oligochromatographic method that was made available recently for the identification and differentiation of mycobacteria. The present study aimed to evaluate the performance of the Speed-Oligo Mycobacteria assay for the identification of NTM. We examined a total of 62 strains (9 type strains, 19 reference strains and 34 clinical isolates) belonging to 13 different species (Mycobacterium intracellulare, M. fortuitum, M. gordonae, M. kansasii, M. marinum, M. peregrinum, M. scrofulaceum, M. abscessus, M. bovis BCG, M. chelonae, M. avium, M. malmoense and M. xenopi). The Speed-Oligo Mycobacteria assay was performed according to the manufacturer's instructions. Discrepant results between Speed-Oligo Mycobacteria and the original identification were reassessed by the Speed-Oligo Mycobacteria assay and resolved by the GenoType Mycobacterium CM assay and by sequencing of 16S rRNA and protein-encoding genes. We found 93.5 % (58/62) concordance for the identification of NTM as compared with the original identification. Three strains were erroneously identified by Speed-Oligo Mycobacteria: one M. kansasii strain was identified as Mycobacterium tuberculosis complex, and one M. chelonae strain and one M. peregrinum strain were both identified as Mycobacterium abscessus. Moreover, one M. chelonae strain was not identified by Speed-Oligo Mycobacteria since it did not react with any species-specific probe. For these strains, sequencing of the genes hsp65, 16S rRNA and rpoB and the GenoType Mycobacterium CM assay were performed. The Speed-Oligo Mycobacteria assay can be a useful tool for the rapid and easy identification of the most common NTM. If applied in clinical practice it could reduce diagnostic delays and contribute to correct clinical and better management of infections caused by NTM.
INTRODUCTION
Nontuberculous mycobacteria (NTM) are ubiquitous environmental micro-organisms. They are considered opportunistic pathogens in humans, and several species are associated with IP: 54.70.40.11
On: Sat, 29 Dec 2018 13:02:45 respiratory infections, lymphadenitis, skin and soft-tissue infections, and disseminated diseases (Foo et al., 2009; Babalik et al., 2012) . The increasing prevalence of disease due to NTM is related both to more intense interactions of humans with certain types of environment and to changes in population demographics, including a growing number of people who are immunosuppressed as a result of HIV/AIDS, malignancy or medical intervention (Heifets, 2004) .
Since clinical management, antimicrobial therapy and infection control measures differ depending on the infecting mycobacterial species, a rapid and accurate diagnostic tool for the reliable identification of NTM is essential (HofmannThiel et al., 2011) . Conventional biochemical tests used to identify mycobacteria are complex, time consuming and can generate misidentification. The introduction of molecular methods has greatly improved the speed and accuracy of the identification process (Singh et al., 2013) .
Recently, a new DNA line probe assay for the differentiation of mycobacteria was made available as a commercial test. The Speed-Oligo Mycobacteria assay (Vircell) is an oligochromatographic method based on PCR targeting 16S rRNA gene and 16S-23S rRNA regions and double reverse hybridization on a dipstick using probes bound to colloidal gold and a membrane. This assay identifies the Mycobacterium genus, Mycobacterium tuberculosis complex and 13 different species of NTM (Quezel-Guerraz et al., 2010; Hofmann-Thiel et al., 2011) . The present study aimed to evaluate the performance of the Speed-Oligo Mycobacteria assay for the identification of NTM.
METHODS
Strains. A total of 62 mycobacterial strains (9 type strains, 19 reference strains and 34 clinical isolates) belonging to 13 different species were used in this study (Tables 1, 2 and 3) and were obtained from the CCUG collection (http://www.ccug.se), from the clinical laboratory of St Luc Hospital, Brussels, and from the WHO supernational reference laboratory for tuberculosis, Milano, Italy. The clinical isolates were previously identified by 16S rRNA gene sequence analysis.
Speed-Oligo Mycobacteria assay. This method identifies the Mycobacterium genus, M. tuberculosis complex (M. tuberculosis, Mycobacterium bovis, Mycobacterium microti, Mycobacterium africanum, Mycobacterium caprae) and 13 different species of NTM (Mycobacterium abscessus, Mycobacterium marinum/Mycobacterium ulcerans complex, Mycobacterium kansasii, Mycobacterium xenopi, Mycobacterium intracellulare, Mycobacterium avium, Mycobacterium scrofulaceum, Mycobacterium malmoense, Mycobacterium gordonae, Mycobacterium interjectum, Mycobacterium chelonae, Mycobacterium fortuitum and Mycobacterium peregrinum). For DNA extraction, a loopful of bacteria from Löwenstein-Jensen medium was resuspended in 150 ml of Vircell sample solution and incubated at 95 uC for 60 min. The bacterial suspension was then centrifuged at 12 000 g for 5 min and the supernatant was used directly for PCR or stored at 220 uC. For PCR, 15 ml of ready-to-use reconstituted PCR mix (provided with the kit) and 10 ml of DNA sample were added to PCR tubes. PCR conditions were 1 min of denaturation at 92 uC, 40 cycles consisting of 20 s at 92 uC, 30 s at 55 uC, 30 s at 72 uC, and a final extension of 1 min at 72 uC. The PCR product was denatured by heating at 95 uC for 1 min and immediately cooled on ice. Then, 10 ml of denatured PCR product was added to 35 ml of preheated (55 uC) hybridization solution (provided with the kit) in a 1.5 ml tube. The test strip was immediately inserted and results were interpreted after 10 min of incubation at 55 uC. Positive (M. tuberculosis DNA) and negative (deionized water) controls were always included in each test run. These controls were provided by the manufacturer. The visual interpretation of the results was based on the presence or absence of different bands and compared with reference bands according to the manufacturer's instructions. The entire process took approximately 150 min.
Resolution of discrepancies. Discrepant results between SpeedOligo Mycobacteria and the original identification methods were reexamined by the Speed-Oligo Mycobacteria assay and resolved by the GenoType Mycobacterium CM assay (Hain Lifescience) and by sequencing of hsp65, 16S rRNA and rpoB genes.
GenoType Mycobacterium CM assay. The GenoType Mycobacterium CM assay was divided into three steps: DNA extraction from cultured material, multiplex amplification with biotinylated primers and a reverse hybridization. The whole procedure was performed as recommended by the manufacturer.
PCR amplification and sequencing. For the PCR amplification of the hsp65, 16S rRNA and rpoB genes we used the primers described by Telenti et al. (1993) , Harmsen et al. (2003) and Adékambi et al. (2003) , respectively. PCR products were purified by using a NucleoFast 96 PCR clean-up kit (Macherey-Nagel). Sequencing reactions were performed by using a BigDye terminator cycle-sequencing kit (Applied Biosystems) and purified using the BigDye X Terminator Purification kit (Applied Biosystems). For sequencing, the primers used were: Tb11 59-ACCAACGATGGTGTGTCCAT and Tb12 59-CTTGTCGAACCG-CATACCCT (for the hsp65 gene), 16S27f 59-AGAGTTTGATCMTGG-CTCAG and BKL1 59-GTATTACCGCGGCTGCTGGCA (for the 16S 
RESULTS
Sixty-two mycobacterial strains were included in the study. A concordance of 93.5 % (58/62) was found in the identification of the NTM between the Speed-Oligo Mycobacteria assay and the routine identification methods (Tables 1, 2 T , respectively. The third discordance was M. kansasii CCUG 32245, which was erroneously identified by Speed-Oligo Mycobacteria as M. tuberculosis complex. The GenoType Mycobacterium CM assay identified this strain correctly as M. kansasii. We found a sequence similarity of 99 % for the 16S rRNA gene, 97 % for the rpoB gene and 92 % for hsp65 gene sequences with the type strain M. kansasii ATCC 12478
T . The last discordant strain, M. peregrinum ATCC 700686, was identified as M. abscessus by Speed-Oligo Mycobacteria. The GenoType Mycobacterium CM assay identified this strain as M. peregrinum. This strain showed sequence similarities of 100 % for the 16S rRNA gene with M. peregrinum ATCC 14467 T and M. septicum ATCC 700731 T , 99 % and 98 % similarity for the rpoB gene sequence with M. peregrinum ATCC 14467 T and M. septicum ATCC 700731 T , and 99 % and 98 % similarity for the hsp65 gene sequence with M. peregrinum ATCC 14467 T and M. septicum ATCC 700731 T type strains ( Table 2 ). The SpeedOligo Mycobacteria assay therefore correctly identified 100 % (9/9) of the type strains, 78.9 % (15/19) of the reference strains and 100 % (34/34) of the clinical isolates evaluated.
DISCUSSION
The recently introduced commercial test Speed-Oligo Mycobacteria allows detection of mycobacteria including M. tuberculosis complex and 13 of the most frequently isolated species of NTM (Fig. S1 , available in the online Supplementary Material) (Quezel-Guerraz et al., 2010) . Its major advantage compared with other line-probe tests comprises its direct application to denatured amplification products. No washing steps are needed compared with similar methods. This dipstick test requires only two pipetting steps, thereby decreasing the hands-on time and the risk of cross-contamination. Results can be obtained within 2 h 30 min with a total hands-on time of 30 min (Hofmann-Thiel et al., 2011; Lara-Oya et al., 2013) . (Pang et al., 2011) . Moreover, the SpeedOligo Mycobacteria failed to identify one strain of M. chelonae, Panel 5 ISP, which did not react with any probe. This may be due to variability of the bacterial genome of this strain (Lara-Oya et al., 2013) .
The species discrepancies found in our study were also found in previous studies. Quezel-Guerraz et al. Speed-Oligo Mycobacteria is a rapid, easy-to-perform and inexpensive method. However, its major current limitation is that it allows the identification of a relatively small spectrum of mycobacterial species only and, therefore, some NTM commonly found in the routine clinical laboratory, such as Mycobacterium goodii, Mycobacterium szulgai and Mycobacterium lentiflavum, may not be identified. This could be solved if additional probes were incorporated into the membrane strip in order to cover more species (Wu et al., 2007) .
We conclude that the Speed-Oligo Mycobacteria test can be considered as a valid tool for the rapid and easy identification of the most frequently occurring species of NTM. If applied in clinical practice, this assay could reduce diagnostic delays and contribute to a targeted therapy and better management of infections caused by NTM. The limitation of this study was the limited number of clinical isolates evaluated. However, evaluation under routine conditions in a multicentre study could prove, more reliably and robustly, the accuracy of this method.
